Functional magnetic resonance imaging of the acute effect of intravenous heroin administration on visual activation in long-term heroin addicts: Results from a feasibility study

Drug and Alcohol Dependence

Volumn 49, Issue 1, 1997, Pages 55-60

  Sell, Louise A ^a   Simmons, Andrew ^a,b   Lemmens, Gilbert M ^a   Williams, Steven C R ^a,b   Brammer, Michael ^a   Strang, John ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Blood oxygenation level dependent (BOLD) signal; fMRI; Functional magnetic resonance imaging; Heroin; Visual activation

Indexed keywords

DIAMORPHINE; OPIATE;

ADULT; ARTICLE; BRAIN FUNCTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ABUSE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPIATE ADDICTION; PRIORITY JOURNAL; VISUAL STIMULATION;

ACUTE DISEASE; ADULT; BRAIN; FEMALE; HEROIN DEPENDENCE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OXYGEN; PHOTIC STIMULATION; SUBSTANCE ABUSE, INTRAVENOUS; TIME FACTORS;

EID: 0031592383     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(97)00140-3     Document Type: Article

References (26)

1. Altman J., Everitt B.J., Glautier S., Markou A., Nutt D., Oretti R., Phillips G.D., Robbins T.W. The biological, social and clinical bases of drug addiction: commentary and debate. Psychopharmacology. 125:1996;285-345.
2. Bloom F.E. The endorphins: a growing family of pharmacologically pertinent petides. Annu. Rev. Phamacol. Toxicol. 23:1983;151-170.
3. Bruhn H., Kleinschmidt A., Boecker H., Merboldt K.D., Hanicke W., Frahm J. The effect of acetazolamide on regional blood oxygenation at rest and under stimulation as assessed by MRI. J. Cereb. Blood Flow Metab. 14:1994;742-748.
4. Bullmore E.T., Brammer M.J., Williams S.C.R., Rabe-Hesketh S., Janot N., David A.S., Mellers J.D.C., Howard R., Sham P. Statistical methods of estimation and inference for functional MR image analysis. Magn. Reson. Med. 35:1996;261-277.
5. Duthie D.J.R., Nimmo W.S. Adverse effects of opioid analgesic drugs. Br. J. Anaesth. 59:1987;61-77.
6. Fanelli R.J., Szikszay M., Jasinsky D.R., London E.D. Differential effects of mu and kappa opioid analgesics on cerebral glucose utilisation in the rat. Brain Res. 422:1987;257-266.
7. Friston K.J., Williams S.C.R., Howard R., Frackowiak R.S.J., Turner R. Movement-related effects in fMRI time series. Magn. Reson. Med. 35:1996;346-355.
8. Hiesinger E.M., Voorhies R.M., Lipschutz L., Basler G., Shapiro W.R., Pasternak G.W. The effects of morphine on glucose metabolism in rat brain as measured by quantitative autoradiography. Soc. Neurosci. 9:1983;138.
9. Howard R.J., Ellis C., Bullmore E.T., Brammer M., Mellers J.D., Woodruff P.W., David A.S., Simmons A., Williams S.C.R., Parkes J.D. Functional echoplanar imaging correlates of amphetamine administration to normal subjects and subjects with the narcoleptic syndrome. Magn. Reson. Imaging. 14:1996;1013-1016.
10. Howseman A.M., Josephs O., Porter D., Muller E., Frackowiak R.S.J., Turner R. Sustained activation in visual cortex using EPI and FLASH fMRI. Neuroimage. 3:1996;58.
11. Ito M., Suda S., Namba H., Sokoloff L., Kennedy C. Effects of acute morphine administration on local cerebral glucose utilisation in rat. J. Cereb. Blood Flow Metab. 3:1983;574-575.
12. Koskinen L.O., Bill A. Regional cerebral, ocular and peripheral effects of naloxone and morphine in unanesthetized rabbits. Acta Physiol. Scand. 119:1983;235-241.
13. Levin J.M., Holman B.L., Mendelson J.H., Teoh S.K., Garada B., Johnson K.A., Springer S. Gender differences in cerebral perfusion in cocaine abuse: Technetium-99-HMPAO SPECT study of drug abusing women. J. Nucl. Med. 3:1994;1902-1909.
14. Levin J.M., Ross M.H., Mendelson J.H., Kaufman M.J., Yurgelun-Todd D.A., Cohen B.M., Renshaw P. Reduction in BOLD response to photic stimulation after ethanol administration. Proc. Soc. Magn. Reson. Vol. 1:1995;162.
15. London E.D., Brousolle E.P.M., Links J.M., Wong D.F., Cascella N.G., Dannals R.F., Sano M., Herning R., Snyder F.R., Rippetoe L.R., Toung T.J.K., Jaffe J.H., Wagner H.N. Morphine-induced metabolic changes in human brain. Arch. Gen. Psychiatry. 47:1990;73-81.
16. London E.D. Positron emission tomography in studies of drug abuse. NIDA Res. Monogr. Ser. 138:1994;15-24.
17. Martin W.R. Pharmacology of opioids. Pharmacol. Rev. 35:1983;283-323.
18. Murray R.B., Adler M.W., Korczyn A.D. The pupillary effects of opioids. Life-Sci. 33:1983;495-509.
19. Ogawa S., Lee T.M., Kay A.R., Tank D.W. Brain magnetic resonance imaging with contrast dependent blood oxygenation. Proc. Natl. Acad. Sci. 87:1990;9868-9872.
20. Pfeiffer A., Pasi A., Mehraein P., Herz A. Opiate receptor binding sites in human brain. Brain Res. 248:1982;87-96.
21. Press, W.H., Flannery, B.P., Teukolsky, S.A., Velterling, W.T., 1988. Numerical recipes in C: The art of scientific computing, Cambridge University Press.
22. Simmons A., Moore E., Williams S.C.R. Automated quality control for functional MRI studies. Neuroimage. 5:1997;S466.
23. Trusk C.T., Stein E.A. Effect of intravenous heroin and naloxone on regional cerebral blood flow in the conscious rat. Brain Res. 406:1987;238-245.
24. Walsh S.L., Gibson S.F., Janinski D.R., Stapleton J.M., Phillips R.L., Dannals R.F., Schmidt J., Preston K.L., Grayson R., Bigelow G.E., Sullivan J.T., Contoregii C., London E.D. Buprenorphine reduces cerebral glucose metabolism in poly drug users. Neuropsychopharmacology. 10:1994;157-170.
25. Wise R.A., Bozarth M.A. A psychomotor stimulant theory of addiction. Psychol. Rev. 94:1987;469-492.
26. Woods S.W. Regional cerebral blood flow imaging with SPECT in psychiatric disease; focus on schizophrenia, anxiety disorders and substance abuse. J. Clin. Psychiatry. 53:1992;20-25.